查看更多>>摘要:目的 探讨穴位埋线联合血脂康胶囊对他汀不耐受高脂血症脾肾阳虚证患者脂代谢及抗氧化能力的影响。 方法 随机对照试验研究。选取2020年7月-2022年6月上海中医药大学附属曙光医院、上海市普陀区中心医院及上海市徐汇区凌云社区卫生服务中心82例他汀不耐受高脂血症患者作为观察对象,采用单双球法随机分为2组,每组41例。2组均进行饮食、运动指导,对照组在此基础上口服血脂康胶囊,观察组在对照组基础上予以穴位埋线。2组均连续治疗3个月。分别于治疗前后进行中医证候评分,记录患者体重、腰围、BMI;采用全自动生化分析仪检测TC、TG、HDL-C、LDL-C水平,ELISA法检测血清SOD、GSH-Px、总抗氧化力(TAOP)水平,放射免疫法检测血清内皮素-1(ET-1)水平;彩色多普勒超声诊断仪检测肱动脉血流介导的内皮依赖性血管舒张功能(FMD)、硝酸甘油介导的非内皮依赖性血管舒张功能(NMD)。 结果 观察组治疗后畏寒肢冷[(1.27±0.12)分比(1.46±0.16)分,t=6.08]、便溏[(1.41±0.16)分比(1.63±0.18)分,t=5.85]、倦怠乏力[(1.45±0.15)分比(1.57±0.17)分,t=3.39]、眩晕[(1.15±0.11)分比(1.26±0.13)分,t=4.14]、食欲不振[(1.21±0.13)分比(1.39±0.15)分,t=5.81]积分低于对照组(P<0.01);体重[(68.03±6.57)kg比(71.55±6.76)kg,t=2.39]、腰围[(85.13±4.63)cm比(87.35±4.85)cm,t=2.12]、BMI[(27.35±2.84)kg/m2比(29.18±3.05)kg/m2,t=2.81]水平低于对照组(P<0.05);血清TC[(3.15±0.13)mmol/L比(3.38±0.17)mmol/L,t=6.88]、TG[(1.98±0.11)mmol/L比(2.21±0.15)mmol/L,t=7.92]、LDL-C[(2.46±0.26)mmol/L比(3.04±0.33)mmol/L,t=8.84]水平低于对照组(P<0.01),HDL-C[(1.88±0.24)mmol/L比(1.74±0.21)mmol/L,t=2.81]水平高于对照组(P<0.01);血清SOD[(57.82±5.84)μg/L比(55.06±5.61)μg/L,t=2.18]、GSH-Px[(96.51±9.52)U/L比(92.26±9.25)U/L,t=2.30]、TAOP[(6.21±0.57)U/L比(5.94±0.54)U/L,t=2.20]水平高于对照组(P<0.05);血清ET-1[(60.43±4.36)pg/L比(63.71±4.68)pg/L,t=3.28]水平低于对照组(P<0.01),FMD[(12.48±1.02)%比(11.34±0.95)%,t=5.24]、NMD[(15.12±1.24)%比(14.44±1.18)%,t=2.54]水平高于对照组(P<0.01)。 结论 穴位埋线联合血脂康胶囊可降低他汀不耐受高脂血症患者的中医证候积分,降低肥胖及血脂水平,增强抗氧化能力,改善血管内皮功能。 Objective To explore the influence of acupoint catgut embedding combined with Xuezhikang capsule on lipid metabolism and antioxidation effect in patients with statin intolerance and hyperlipidemia of spleen-kidney yang deficiency syndrome. Methods Randomized controlled trial. A total of 82 patients with statin intolerance and hyperlipidemia who were treated in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine , Shanghai Puto Area Central Hospital, and Lingyun community health Service center, Xuhui District from July 2020 to June 2022 were selected and randomly divided into two groups with 41 patients in each group by odd-even ball method. The two groups were given diet and exercise guidance, and the control group was given Xuezhikang capsule orally on this basis, and the observation group was given poly(l-lactide-co-glycolide) (PLGA) thread acupoint catgut embedding on the basis of the control group. Both groups were treated continuously for 3 months. The TCM syndromes were scored before and after treatment, and body weight (BW), waist circumference (WC) and body mass index (BMI) were recorded. The levels of TC, TG, HDL-C and LDL-C were detected by fully automatic biochemical analyzer. The levels of serum SOD, GSH-Px and total antioxidant capacity (TAOP) were measured by ELISA. The level of serum endothelin-1 (ET-1) was assessed by radioimmunoassay. Color Doppler ultrasound diagnostic instrument was used to detect the brachial artery flow-mediated dilation (FMD) and nitroglycerin-mediated dilation (NMD). Results The scores of chilly sensation and cold limbs [(1.27±0.12) vs. (1.46±0.16), t=6.08], loose stool [(1.41±0.16)vs. (1.63±0.18), t=5.85], fatigue [(1.45±0.15) vs. (1.57±0.17), t=3.39], dizziness [(1.15±0.11) vs. (1.26±0.13),t=4.14] and loss of appetite [(1.21±0.13) vs. (1.39±0.15), t=5.81] in observation group after treatment were significantly lower than those in the control group (P<0.01). BW [(68.03±6.57)kgvs. (71.55±6.76)kg, t=2.39], WC [(85.13±4.63)cm vs. (87.35±4.85)cm, t=2.12] and BMI [(27.35±2.84)kg/m2 vs. (29.18±3.05)kg/m2, t=2.81]were lower than those in the control group (P<0.05). The levels of serum TC [(3.15±0.13)mmol/Lvs. (3.38±0.17)mmol/L, t=6.88], TG [(1.98±0.11)mmol/L vs. (2.21±0.15)mmol/L,t=7.92]and LDL-C [(2.46±0.26)mmol/L vs. (3.04±0.33)mmol/L,t=8.84]were significantly lower compared with those in control group (P<0.01) while the level of HDL-C [(1.88±0.24)mmol/Lvs. (1.74±0.21)mmol/L, t=2.81]was higher than that of the control group (P<0.01). The levels of serum SOD [(57.82±5.84)μg/Lvs. (55.06±5.61)μg/L, t=2.18], GSH-Px [(96.51±9.52)U/L vs. (92.26±9.25)U/L, t=2.30]and TAOP [(6.21±0.57)U/L vs. (5.94±0.54)U/L,t=2.20]were significantly higher compared to control group (P<0.05). Serum ET-1 [(60.43±4.36) pg/Lvs. (63.71±4.68) pg/L, t=3.28] level was significantly lower than that in control group (P<0.01), while FMD [(12.48±1.02)%vs. (11.34±0.95)%, t=5.24] and NMD [(15.12±1.24)% vs. (14.44±1.18)%, t=2.54] were significantly higher than those in control group (P<0.01). Conclusion The combination of acupoint catgut embedding and Xuezhikang capsule can reduce the scores of TCM syndromes, lower the obesity and blood lipids, enhance the antioxidant function and improve the vascular endothelial function in patients with statin intolerance and hyperlipidemia.